The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2020 | The pathways of CLL pathogenesis and CLL’s relationship with MBL
Kostas Stamatopoulos, MD, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses whether there is one or multiple pathways to developing chronic lymphocytic leukemia (CLL). Dr Stamatopoulos also discusses the potential relationship between CLL and monoclonal B-cell lymphocytosis (MBL), and how this can develop our understanding of the disease. This interview was recorded during an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
